Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000930976 | SCV001076636 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004704334 | SCV005206121 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004958300 | SCV005492685 | likely benign | Inborn genetic diseases | 2024-11-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001832117 | SCV002095541 | likely benign | Dyskeratosis congenita | 2020-10-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004735894 | SCV005342127 | likely benign | RTEL1-related disorder | 2024-03-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |